Correlation Between AbbVie and Haw Par
Can any of the company-specific risk be diversified away by investing in both AbbVie and Haw Par at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and Haw Par into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and Haw Par, you can compare the effects of market volatilities on AbbVie and Haw Par and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of Haw Par. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and Haw Par.
Diversification Opportunities for AbbVie and Haw Par
Excellent diversification
The 3 months correlation between AbbVie and Haw is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and Haw Par in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Haw Par and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with Haw Par. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Haw Par has no effect on the direction of AbbVie i.e., AbbVie and Haw Par go up and down completely randomly.
Pair Corralation between AbbVie and Haw Par
Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the Haw Par. In addition to that, AbbVie is 2.66 times more volatile than Haw Par. It trades about -0.06 of its total potential returns per unit of risk. Haw Par is currently generating about 0.18 per unit of volatility. If you would invest 767.00 in Haw Par on September 12, 2024 and sell it today you would earn a total of 68.00 from holding Haw Par or generate 8.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AbbVie Inc vs. Haw Par
Performance |
| Timeline |
| AbbVie Inc |
| Haw Par |
AbbVie and Haw Par Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and Haw Par
The main advantage of trading using opposite AbbVie and Haw Par positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, Haw Par can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Haw Par will offset losses from the drop in Haw Par's long position.| AbbVie vs. Puma Biotechnology | AbbVie vs. Iovance Biotherapeutics | AbbVie vs. Sarepta Therapeutics | AbbVie vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |